TGFB1 and idiopathic pulmonary fibrosis: Sulforaphane (SFN) was found to enhance antioxidant capacity, reverse TGF-β-induced interstitial changes, return cells to epithelioid morphology, and exhibit significant antifibrotic effects on IPF patients, TGF-β-treated cell lines, and BLm-induced fibrosis in mice [36,37].